Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research interests include Nanoplatforms for cancer theranostics, Advanced biosensing and bioanalysis techniques, Immune cells in cancer, and Nanoparticle-Based Drug Delivery.
Supplementary Data1 from Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Table S1 - Representation1 from Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Supplementary Data2 from Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Data from Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Intramolecular control of click-to-release chemistry unlocks fast and quantitative bioorthogonal bond cleavage in living systems
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models
Erasable FAP Targeted Spray‐On Probe for Fluorescence‐Guided Surgery
DEG table1 from Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Advances and challenges in precision imaging
Fluorinated Ribonucleocarbohydrate Nanoparticles Allow Ultraefficient mRNA Delivery and Protein Expression in Tumor-Associated Myeloid Cells
Ex vivo machine perfusion as a platform for lentiviral gene delivery in rat livers
Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence
Tracking inflammation status for improving patient prognosis: A review of current methods, unmet clinical needs and opportunities
Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer
Targeting cancer-associated fibroblasts for real-time intraoperative tumor identification with a spray-on fluorescent probe
Fluorescent PSMA-Targeted Radiotheranostic Compounds for Multiscale Imaging
Next-Level Bioorthogonal Bond-Cleavage Through Intramolecular Control of Click-To-Release Chemistry
Far-Red Spray-On Imaging Probes for FAP-Targeted Cancer Surgery
Radiation-Triggered Payload Release Enhances Bispecific Antibody Efficacy
Data from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Supplementary Figure S5 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
A Myeloid Cell-Targeted Immunostimulant Cocktail (MyTai) Enhances Cancer Immunotherapy
Supplementary Table S2 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Supplementary Figure S6 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Integrated Multi‐Channel Automatic Cellular Profiling (iMAP) System for Cholangiocarcinoma Diagnosis
Supplementary Figure S1 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer
Supplementary Figure S3 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Supplementary Figure S4 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response
Supplementary Figure S2 from Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin–Drug Conjugate Response